Fact CheckerSign in

NCT07567482Recruiting

Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease

Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease: A Mixed-Methods Study of Effectiveness and Acceptability

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

This study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laboratory sessions. The first session includes clinical assessments, fitting and familiarization with the exoskeleton, and interviews to explore user perceptions. The second session involves performing functional mobility tasks (e.g., walking, standing, turning) with and without the exoskeleton and under different assistance levels, while movement is measured using wearable sensors. The study will assess the immediate effects of the exoskeleton on mobility, compare assistance levels, identify which participants benefit most, and explore user experience and acceptability. Findings will help inform the development and implementation of assistive technologies to support mobility in healthy aging and in individuals with Parkinson's disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
26 (estimated)
First submitted
17 Apr 2026
Start date
30 Apr 2026
Primary completion date
31 Oct 2026
Lead sponsor
Centre intégré de santé et de services sociaux de l'Outaouais
NCT number
NCT07567482

What you commit to

  • Study type: Interventional
  • Planned participants: 26
  • From 30 Apr 2026 to the primary completion date, 31 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe vascular conditions of the lower limbs that may limit mobility or pose a risk.
  • Severe cognitive impairment (MoCA \< 21)
  • Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease.
    • Healthy elderly participants without Parkinson's disease
  • Severe vascular conditions of the lower limbs that may limit mobility or pose a risk.
  • Severe cognitive impairment (MoCA \< 21)
  • Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility

Other

  • Height smaller than 152 cm
  • Presence of any implantable or external life-sustaining medical device such as a pacemaker
  • Severe osteoporosis or high risk of fractures
  • Contra-indication to the required physical effort
  • Height smaller than 152 cm
  • Presence of any implantable or external life-sustaining medical device such as a pacemaker
  • Severe osteoporosis or high risk of fractures
  • Contra-indication to the required physical effort

Who the study is looking for

  • Ability to walk for at least 30 minutes with or without minimal aid
  • Diagnosis of idiopathic Parkinson's disease
  • Hoehn and Yahr stage 1 to 4
  • Ability to walk for at least 30 minutes with or without minimal aid
  • Age ≥ 65 years old

Criteria the registry did not label

  • Participants with Parkinson's disease

Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
TechCare Research Lab - CISSS de l'Outaouais
Coordinator of this site? Confirm its status
GatineauCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.